New protein-targeting drug shows promise in early trial for patients with high …

Filed under: Portland Drug Rehab Centers

A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL), according to a study led in part by Dana-Farber Cancer Institute …
Read more on HealthCanal.com

Young Children Who Miss Well-Child Visits are More Likely to be Hospitalized

Filed under: Portland Drug Rehab Centers

“Well-child visits are important because this is where children receive preventive immunizations and develop a relationship with their provider,” says study lead author Jeffrey Tom, MD, MS, an assistant investigator with the Kaiser Permanente Center …
Read more on HealthCanal.com